Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment. | Evid Based Complement Alternat Med | 2022 | 36185088 | PubTator, text mining | PubMed |
| PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC. | Comput Math Methods Med | 2022 | 36176741 | PubTator, text mining | PubMed |
| Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis. | Front Pharmacol | 2022 | 36176446 | PubTator, text mining | PubMed |
| Proteomics Combined with RNA Sequencing to Screen Biomarkers of Sepsis. | Infect Drug Resist | 2022 | 36172619 | PubTator, text mining | PubMed |
| A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma. | Front Genet | 2022 | 36171884 | PubTator, text mining | PubMed |
| Development and validation of an epithelial-mesenchymal transition-related gene signature for predicting prognosis. | World J Clin Cases | 2022 | 36159424 | PubTator, text mining | PubMed |
| Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma. | Front Oncol | 2022 | 36158685 | PubTator, text mining | PubMed |
| Microarray analysis reveals the potential molecular mechanism of Lp299v in stable coronary atherosclerotic disease. | AMB Express | 2022 | 36152115 | PubTator, text mining | PubMed |
| Transcriptome sequencing analysis of echovirus 30 infection reveals its potential pathogenesis. | Front Microbiol | 2022 | 36147849 | PubTator, text mining | PubMed |
| Regulation and coordination of the different DNA damage responses in Drosophila. | Front Cell Dev Biol | 2022 | 36147740 | PubTator, text mining | PubMed |
| Primary Cilia Influence Progenitor Function during Cortical Development. | Cells | 2022 | 36139475 | PubTator, text mining | PubMed |
| CtIP Regulates Mitotic Spindle Assembly by Modulating the TPX2-Aurora A Signaling Axis. | Cells | 2022 | 36139389 | PubTator, text mining | PubMed |
| Tubulin deacetylase NDST3 modulates lysosomal acidification: Implications in neurological diseases. | Bioessays | 2022 | 36135988 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein-Barr Virus Infection. | Curr Oncol | 2022 | 36135044 | PubTator, text mining | PubMed |
| Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. | Front Oncol | 2022 | 36119527 | PubTator, text mining | PubMed |
| A novel necroptosis-related gene signature for predict prognosis of glioma based on single-cell and bulk RNA sequencing. | Front Mol Biosci | 2022 | 36111134 | PubTator, text mining | PubMed |
| Structural, enzymatic and spatiotemporal regulation of PP2A-B55 phosphatase in the control of mitosis. | Front Cell Dev Biol | 2022 | 36105360 | PubTator, text mining | PubMed |
| Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. | J Hematol Oncol | 2022 | 36104717 | PubTator, text mining | PubMed |
| NudCD1 as a prognostic marker in colorectal cancer and its role in the upregulation of cellular spindle assembly checkpoint genes and LIS1 pathways. | BMC Cancer | 2022 | 36104662 | PubTator, text mining | PubMed |
| Integrated Analysis of the lncRNA-Associated ceRNA Network in Wilms Tumor via TARGET and GEO Databases. | Genet Res (Camb) | 2022 | 36101743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=32